Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Angeliki Ditsiou"'
Autor:
Viviana Vella, Angeliki Ditsiou, Anna Chalari, Murat Eravci, Sarah K. Wooller, Teresa Gagliano, Cecilia Bani, Emanuela Kerschbamer, Christos Karakostas, Bin Xu, Yongchang Zhang, Frances M.G. Pearl, Gianluca Lopez, Ling Peng, Justin Stebbing, Apostolos Klinakis, Georgios Giamas
Publikováno v:
Advanced Science, Vol 11, Iss 15, Pp n/a-n/a (2024)
Abstract Temozolomide (TMZ) represents the cornerstone of therapy for glioblastoma (GBM). However, acquisition of resistance limits its therapeutic potential. The human kinome is an undisputable source of druggable targets, still, current knowledge r
Externí odkaz:
https://doaj.org/article/10bdea1081e24054b2aa80185b300ab8
Autor:
Chiara Cilibrasi, Angeliki Ditsiou, Athanasios Papakyriakou, George Mavridis, Murat Eravci, Justin Stebbing, Teresa Gagliano, Georgios Giamas
Publikováno v:
Molecular Cancer, Vol 20, Iss 1, Pp 1-6 (2021)
Externí odkaz:
https://doaj.org/article/b59ea63d0ff94693a76f0047ff8b09b0
Autor:
Chiara Cilibrasi, Angeliki Ditsiou, Athanasios Papakyriakou, George Mavridis, Murat Eravci, Justin Stebbing, Teresa Gagliano, Georgios Giamas
Publikováno v:
Molecular Cancer, Vol 20, Iss 1, Pp 1-3 (2021)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/fac5be7e78004bf4b01243ad2c9e493c
Autor:
Angeliki Ditsiou, Teresa Gagliano, Mark Samuels, Viviana Vella, Christos Tolias, Georgios Giamas
Publikováno v:
Open Biology, Vol 11, Iss 9 (2021)
In the last decade, LMTK3 (lemur tyrosine kinase 3) has emerged as an important player in breast cancer, contributing to the advancement of disease and the acquisition of resistance to therapy through a strikingly complex set of mechanisms. Although
Externí odkaz:
https://doaj.org/article/fcf184c504b24402a9e6d4ca45afe2bb
Autor:
Giulia Bresciani, Angeliki Ditsiou, Chiara Cilibrasi, Viviana Vella, Federico Rea, Marco Schiavon, Narciso Giorgio Cavallesco, Georgios Giamas, Maria Chiara Zatelli, Teresa Gagliano
Publikováno v:
Endocrine Connections, Vol 8, Iss 6, Pp 680-690 (2019)
Broncho-pulmonary neuroendocrine neoplasms (BP-NENs) are neoplasms orphan of an efficient therapy. Available medical treatments derived from clinical trials are not specific for the management of this malignancy. Sunitinib is a multi-receptor tyrosin
Externí odkaz:
https://doaj.org/article/bfba6096118e412693edee0a4ec7a5fb
Autor:
Viviana Vella, Angeliki Ditsiou, Anna Chalari, Murat Eravci, Sarah K Wooler, Teresa Gagliano, Cecilia Bani, Emanuela Kerschbamer, Frances M.G. Pearl, Gianluca Lopez, Ling Peng, Justin Stebbing, Apostolos Klinakis, Georgios Giamas, Bin Xu, Yongchang Zhang
Temozolomide (TMZ) represents the cornerstone of therapy for glioblastoma (GBM). However, acquisition of resistance limits its therapeutic potential and therefore poses the need to identify new therapeutic combinations that could improve treatment ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbb1337a726773c99ffb58f5e21b2293
https://doi.org/10.21203/rs.3.rs-2731966/v1
https://doi.org/10.21203/rs.3.rs-2731966/v1
Autor:
Alessandro Agnarelli, Andrea Lauer Betrán, Athanasios Papakyriakou, Viviana Vella, Mark Samuels, Panagiotis Papanastasopoulos, Christina Giamas, Erika J. Mancini, Justin Stebbing, John Spencer, Chiara Cilibrasi, Angeliki Ditsiou, Georgios Giamas
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 1; Pages: 865
Recently, the oncogenic role of lemur tyrosine kinase 3 (LMTK3) has been well established in different tumor types, highlighting it as a viable therapeutic target. In the present study, using in vitro and cell-based assays coupled with biophysical an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f064db5c51a6f85ba15131b63961cb49
Publikováno v:
Cancer Gene Therapy. 29:1077-1079
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::365382b7b713ab046226f2d528ddcf71
https://doi.org/10.1038/s41417-021-00408-3
https://doi.org/10.1038/s41417-021-00408-3
Autor:
George Mavridis, Teresa Gagliano, Angeliki Ditsiou, Murat Eravci, Justin Stebbing, Athanasios Papakyriakou, Georgios Giamas, Chiara Cilibrasi
Publikováno v:
Molecular Cancer, Vol 20, Iss 1, Pp 1-3 (2021)
Molecular Cancer
Molecular Cancer
Correction to: Mol Cancer 20, 53 (2021)\ud \ud https://doi.org/10.1186/s12943-021-01345-3\ud \ud Following the publication of the original article [1], the authors noticed errors on the figures introduced during the production step. Below are the err
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8644e4a68814360e87dc4d273cd5e55
https://doaj.org/article/fac5be7e78004bf4b01243ad2c9e493c
https://doaj.org/article/fac5be7e78004bf4b01243ad2c9e493c
Autor:
Georgios Giamas, Viviana Vella, Christos Tolias, Teresa Gagliano, Mark Samuels, Angeliki Ditsiou
Publikováno v:
Open Biology
Open Biology, Vol 11, Iss 9 (2021)
Open Biology, Vol 11, Iss 9 (2021)
In the last decade, LMTK3 (lemur tyrosine kinase 3) has emerged as an important player in breast cancer, contributing to the advancement of disease and the acquisition of resistance to therapy through a strikingly complex set of mechanisms. Although
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67f78e3c37b4268c6c9d32eebd4680c4
https://pubmed.ncbi.nlm.nih.gov/34582708
https://pubmed.ncbi.nlm.nih.gov/34582708